Sheba Medical Center
Ramat Gan, Israel
NCT Number: NCT02093676
It is presumed that families of poorly controlled diabetic adolescents (type 1) would benefit from parents' counselling, guided by "the New Authority" model.
Looking for future studies?
Notify Me12 year–17 year
All sexes
Interventional
Not applicable
Ramat Gan, Israel
"The New Authority" model has been shown to be helpful in risk behaviors such as children's violence and school refusal. It is assumed the model would prove helpful in the risk behavior of lack of adherence to diabetes treatment regimen. The treatment is give to parents only, without the adolescent's participation. It is predicted to improve self care, parents' monitoring, family conflict and parents' helplessness.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Other names: "The New Authority" model
Time frame: assessment at 4 points: enrty, after 3 months, after 6 months and after 9 months
Time frame: assessment at four points: entry, after 3 months, after 6 months and after 9 months
self care inventory questionnaire
Time frame: assessment at four points: entry, after 3 months, after 6 months and after 9 months
parents' helplessness questionnaire
Time frame: assessment at four points: entry, after 3 months, after 6 months and after 9 months
diabetes family conflict scale
Time frame: assessment at four points: entry, after 3 months, after 6 months and after 9 months
parental monitoring of diabetes
Sheba Medical Center
Other Gov
Development and Assessment of a Treatment Protocol for Poorly Controlled Diabetic (Type 1) Adolescents, Based on "The New Authority" Model
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01897688
Autoimmune Diseases, Diabetes Mellitus
Chicago, Illinois, United States
View Trial DetailsNCT06494722
Autoimmune Diseases, Diabetes Mellitus
Atlanta, Georgia, United States
View Trial DetailsNCT05229718
Autoimmune Diseases, Diabetes Mellitus
Boston, Massachusetts, United States
View Trial DetailsNCT01354288
Acid-Base Imbalance, Acidosis
Le Kremlin-Bicêtre, France
View Trial Details